Litigation Details for Mayor and City Council of Baltimore v. Astrazeneca Pharmaceuticals LP (D. Del. 2020)
✉ Email this page to a colleague
Mayor and City Council of Baltimore v. Astrazeneca Pharmaceuticals LP (D. Del. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-10-29 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 28:1332 | Assigned To | Colm Felix Connolly |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,923,984 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Mayor and City Council of Baltimore v. Astrazeneca Pharmaceuticals LP
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Mayor and City Council of Baltimore v. Astrazeneca Pharmaceuticals LP (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-09-24 | 1 | are described in U.S. Pat. No. 6,923,984, incorporated herein by reference… expiration of U.S. Patent No. 5,948,437 (the “’437 Patent”), a follow-on patent, which supposedly covered…invalid patents or to invent around such patents by creating non-infringing generics. E. Patents Are… is the owner of U.S. Patent No. 4,879,288 (“the ’288 Patent”). The ’288 Patent issued on November 7,…’637B Patent. By issuing the Handa ’637A Patent and Handa ’637B Patent despite AstraZeneca's ’288 | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
